Log In
Print this Print this

UroGenRA Kidney

  Manage Alerts
Collapse Summary General Information
Company Cancer Genetics Inc.
DescriptionGenomic microarray assay that uses comparative hybridization to classify renal tumors into the 4 major subtypes
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose the subtypes of renal cell carcinoma (RCC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today